LENALIDOMID Sandoz caps 2.5 mg 21 pce

7680674560081 CH-67456 L04AX04 07.16.4.

Reimbursement limitations:

LENALI.SA.09

LENALIDOMID SANDOZ en association avec l’ixazomib et la dexaméthasone
Après accord sur la prise en …

LENALIDOMID Sandoz caps 2.5 mg 21 pce
LENALIDOMID Sandoz caps 2.5 mg 21 pce
LENALIDOMID Sandoz caps 2.5 mg 21 pce
1 / 3
google

Details

Product number
6745601
CPT
-
Packaging group
21
Unit
Kapsel(n)
Composition
lenalidomidum 2.5 mg, cellulosum microcristallinum, lactosum 33.2 mg, carmellosum natricum conexum corresp. natrium 0.089 mg, magnesii stearas, gelatina, E 171, E 172 (flavum), E 132, lacca, Drucktinte: E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula.

Articles (1)

Lenalidomid Sandoz 2.5 mg, Kapseln
Kapseln
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/10/2025
Professional SmPC
Français
18/10/2025
Professional SmPC
Italien
18/10/2025
Patient information leaflet
Allemand
09/01/2023
Patient information leaflet
Français
09/01/2023
Patient information leaflet
Italien
09/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
33.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
0.089 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 766.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2022

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
67456
Drug name
Lenalidomid Sandoz, Kapseln
Galenic form
KAPS
ATC Code
L04AX04
Authorization status
Z
Dispensation category
A
First authorization
05/05/2020
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
LENALIDOMID Sandoz caps 2.5 mg 21 pce
Description (DE)
LENALIDOMID Sandoz Kaps 2.5 mg 21 Stk
Market launch
05/05/2020
Narcotic (BTM)
No

Original drug

REVLIMID, Hartkapseln
CHF 2480.50
View original

Other packaging sizes

LENALIDOMID Sandoz caps 5 mg 21 pce
21 KAP
View
LENALIDOMID Sandoz caps 7.5 mg 21 pce
21 KAP
View